Clinical Trial Update: A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of an anti-TSLP antibody (GSK5784283) in adults with uncontrolled asthma; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK5784283

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: ACTIVE_NOT_RECRUITING